Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CESIUM-137 MICROSEED SOURCE TRAIN ASSEMBLY/SHIELD

K-Number: K894409 · 1989-09-29

ApplicantAmersham Corp.
Decision Date1989-09-29
Product CodeIWA
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

CESIUM-137 MICROSEED SOURCE TRAIN ASSEMBLY/SHIELD is the device name listed in this FDA 510(k) record. The listed applicant is Amersham Corp.. It received FDA 510(k) clearance on 1989-09-29 under 510(k) number K894409. The device is classified under product code IWA. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CESIUM-137 MICROSEED SOURCE TRAIN ASSEMBLY/SHIELD?

CESIUM-137 MICROSEED SOURCE TRAIN ASSEMBLY/SHIELD is a medical device that received FDA 510(k) clearance on 1989-09-29. The listed applicant is Amersham Corp.. The 510(k) number is K894409.

When did CESIUM-137 MICROSEED SOURCE TRAIN ASSEMBLY/SHIELD receive FDA 510(k) clearance?

CESIUM-137 MICROSEED SOURCE TRAIN ASSEMBLY/SHIELD received FDA 510(k) clearance on 1989-09-29, under 510(k) number K894409.

Who is the listed applicant for CESIUM-137 MICROSEED SOURCE TRAIN ASSEMBLY/SHIELD?

The FDA 510(k) record lists Amersham Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CESIUM-137 MICROSEED SOURCE TRAIN ASSEMBLY/SHIELD?

The FDA product code for CESIUM-137 MICROSEED SOURCE TRAIN ASSEMBLY/SHIELD is IWA.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Amersham Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K914135AMERLITE(TM) PROLACTIN-30 ASSAY, LAN.0086/2086K912733AMERLEX-M SPECIFIC ESTROL(UNCONJUGATED) RIA KITK912766AMERLITE CK-MB ASSAYK904666AMERLITE TSH-60 ASSAY PRODUCT CODE: LAN. 0008/2008K902760AMERSHAM TSH CONTROL SERAK901832GADOLINIUM-153 BONE DENSITOMETER SOURCES GDC.10415

View all 94 devices →

Related Devices (Code: IWA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K915253IR-192 IMPLANT, MODIFICATIONOmnitron Intl., Inc.K874895IR-192 IMPLANTRads S.L., Inc.K850382IRIDIUM SEEDSRadiation Safety & Nuclear Products, Inc.K844248IR-192 IMPLANTRads S.L., Inc.K850163IRIDIUM 192 WIRESSyncor Intl. Corp.K850726WIRE CUTTERS, BRACHYTHERAPY-TABLE TOP & HAND HELDSyncor Intl. Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑